Modules 2.3 & 2.4 Flashcards

1
Q

What is the definition of asthma?

A
  • Chronic inflammatory resp. disease that is a reversible narrowing of the airways
  • Reduces expiratory flow rates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathophys of asthma?

A
  • release of inflammatory mediators results in airway hyper-responsiveness and bronchoconstriction
  • subsequent airway oedema and mucous hypersecretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are pharmaceutical management solutions for asthma?

A

B2 agonists (salbutamol)
Antimuscarinic agents (ipratropium (block M3 receptors associated with stimulation of bronchioles))
Corticosteroids (beclomethasone)
Methylxanthines (-phylline, acts of cAMP levels)
Leukotriene receptor antagonist (montelukast (block Leukotriene in airways alleviating inflammation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is chronic bronchitis and its pathophys?

A
  • inflam. of the bronchi lasting more than 3 months due to lasting irritant exposure, is classed under COPD
    PATHOPHYS:
  • inflammation of bronchi lining
  • hypertrophy of goblet cells leading to inc. mucous production
  • decreased cilia movement and pathogen removal
  • inflam and mucous obstruct airways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the clinical manifestations of chronic bronchitis?

A
  • cough, wheezing, hypoxemia, resp. acidosis, cyanosis, infection
  • leads to P. HTN and R. Sided HF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is emphysema and its pathophys?

A
  • chronic enlargement of terminal bronchioles and loss of elasticity in alveoli
    PATHOPHYS:
  • destruction of alveoli elasticity due to irritant exposure
  • causes alveolar collapse durign exhalation
  • causes enlarged alveoli due to gas trapping, reduced surface area for gas exhacnge
  • exposure to irritants triggers inflam response, leading to chem. mediator and macrophage activity which destroys alveolar proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical manifestations of emphysema?

A
  • breathing difficulties, postural adaptations, barrel chest, weight loss, hypoxemia/capnia, resp. acidosis
  • leads to P HTN and R sided HF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is CF and its pathophys?

A

Inherited disorder affecting many body systems
- Affects CFTR (salt transport protein) and affects secretion of CL and resorption of Na and H2O, affecting mucosal surfaces of epi. cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does CF affect each the resp. system?

A

Resp: blocks airway due to mucous build up, infection risk and inflam., causes bronchiectasis (scarred ariways) and resp failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Sleep apnoea?

A
  • irregular breathing patterns while asleep leading to cessation of breaths
  • two types: Obstructive Sleep apnoea (blockage of airways)
    Central sleep apnoea (brain intermittently stops making effort to breathe, CNS related)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the treatment for sleep apnoea?

A
  • CPAP device
  • mouth piece to wear while asleep
  • surgical interventions (jawbone realignment)
  • lifestyle adjustments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a restrictive lung disease?

A

An inability to expand lungs properly due to stiff lung tissue or external mechanical issues
- causes reduced lung volumes and gas exchange
- difficulty getting air into the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the causes of a restrictive lung disease?

A
  • resp. centre issues (brainstem)
  • chest wall problems (scoliosis)
  • Diaphragm issues (paralysis)
  • Neuromuscular deficits
  • pleural issues ?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is neonatal respiratory distress syndrome (NRDS)?

A
  • interstitial lung disease due to deficiency in pulmonary surfactant due to immature lungs
  • VQ mismatch and lead to parenchymal dysfunction causing hypoxia/capnia
  • Cuases hypoxic P. vasoconstriction and P. HTN, triggers inflam response, inc. cap permeability and pulmonary oedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is pneumoconiosis?

A
  • Chronic restrictive disease caused from long-term exposure to irritants
  • inflam and fibrous tissue develop, connective tissue destroyed
  • functional areas of lungs are lost due to fibrosis extension
  • inspiration becomes difficult as lung compliance dec., infection chance is inc.
  • tissue damage becomes irreversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Pulmonary odema?

A
  • fluid collection in alveoli, reducing O2 diffusion into blood and affects lung expansion and blood oxygenation
  • caused by lung inflam, low plasma protein levels and P. HTN
17
Q

What are the causes of neuromuscular and non-neuromuscular extra-parenchymal restrictive lung diseases?

A
  • neurological, neuromuscular and myopathic
  • diaphragmatic compression, chest wall deformity, disease of the pleura, pneumothorax, pleural effusion
18
Q

What are e.g’s of extra-parenchymal conditions?

A
  • scoliosis, polio, muscular dystrophy, pneumothorax
19
Q

What is a pleural effusion?

A
  • excessive fluid in pleural cavity, pleurisy is condition in which pleural membranes are inflamed, swollen and rough
    types of fluids:
  • exudative: from inflam due to inc. permeability where proteins and WBC leak
  • transudates: watery, due to inc. hydrostatic pressure or dec. osmotic pressure
  • haemothorax: blood due to trauma
  • empyema: purulent due to infection
20
Q

What is a pneumothorax?

A
  • air in pleural cavity due to rupture (open is air from environment, closed is from airways)
  • 3 types are spontaneous, traumatic and tension
  • leads to atelectasis